Own cookie, it is used to store the user's consent for cookies in the "Non Necessary" category. Own cookie, is used to store the user's consent for cookies in the "Necessary" category. It does not store any personal data.įunction of accepting cookies on websites Own cookie, is used to record whether or not the user has consented to the use of cookies. These cookies do not store any personal information. This category only includes cookies that ensures basic functionalities and security features of the website. Necessary cookies are absolutely essential for the website to function properly.
With over 15 years research and development in cardiovascular health genomics GENinCode has amassed a deep knowledge and understanding of the interactions between a patient’s genetic profile, lifestyle and clinical risk factors. Our molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. Our products help inform patients of their health risk enabling them to make behavioural or ‘lifestyle’ changes whilst providing doctors with greater genetic insight and clinical information to determine the most effective treatment pathway (precision medicine). GENinCode products combine genetic and clinical data to risk assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.
GENinCode specializes in cardiovascular disease risk.
0 kommentar(er)
